- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Scitex adds staff for sales campaign
Scitex Medical Systems isretooling its sales organization to give the company more marketingclout in the U.S. The Israeli firm, which markets a line of plain-paperprinters, has moved vice president Michael Braunold from corporateheadquarters in Herzlia,
Scitex Medical Systems isretooling its sales organization to give the company more marketingclout in the U.S. The Israeli firm, which markets a line of plain-paperprinters, has moved vice president Michael Braunold from corporateheadquarters in Herzlia, Israel, to the U.S. to oversee the company'sOEM and direct sales effort in North America.
Scitex of Fanwood, NJ, debuted the UniTone and VariTone printersat last year's Radiological Society of North America meeting (SCAN1/19/94). The printers are designed to produce hard-copy printsfor referring physicians at a price point between thermal printersand laser printers.
Scitex has OEM agreements with Picker, Philips and Diasonics,and several other OEM deals are pending. Scitex also plans todevelop a direct sales channel for UniTone and VariTone.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
